PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,842,530 | -36.8% | 840,809 | +14.7% | 0.02% | -33.3% |
| Q2 2023 | $29,810,622 | -12.8% | 732,988 | +3.9% | 0.03% | -18.9% |
| Q1 2023 | $34,175,292 | -5.2% | 705,518 | -25.3% | 0.04% | -7.5% |
| Q4 2022 | $36,066,032 | -31.8% | 944,879 | -10.4% | 0.04% | -36.5% |
| Q3 2022 | $52,910,000 | +38.6% | 1,053,985 | +10.6% | 0.06% | +40.0% |
| Q2 2022 | $38,169,000 | -1.4% | 952,787 | -8.2% | 0.04% | +25.0% |
| Q1 2022 | $38,705,000 | -18.7% | 1,037,390 | -13.2% | 0.04% | -7.7% |
| Q4 2021 | $47,596,000 | +6.6% | 1,194,980 | -0.4% | 0.04% | -2.5% |
| Q3 2021 | $44,635,000 | -12.7% | 1,199,533 | -0.9% | 0.04% | -9.1% |
| Q2 2021 | $51,149,000 | -7.6% | 1,210,059 | +3.5% | 0.04% | -17.0% |
| Q1 2021 | $55,354,000 | -6.8% | 1,169,055 | +20.1% | 0.05% | 0.0% |
| Q4 2020 | $59,421,000 | +44.5% | 973,643 | +10.7% | 0.05% | +26.2% |
| Q3 2020 | $41,115,000 | -9.4% | 879,471 | -1.7% | 0.04% | -22.2% |
| Q2 2020 | $45,390,000 | +2.2% | 894,567 | -10.2% | 0.05% | -21.7% |
| Q1 2020 | $44,430,000 | -12.8% | 995,970 | -6.1% | 0.07% | +19.0% |
| Q4 2019 | $50,940,000 | +85.6% | 1,060,586 | +30.7% | 0.06% | +70.6% |
| Q3 2019 | $27,450,000 | -27.1% | 811,644 | -3.1% | 0.03% | -27.7% |
| Q2 2019 | $37,675,000 | +13.4% | 837,222 | -5.1% | 0.05% | +9.3% |
| Q1 2019 | $33,223,000 | -2.8% | 882,636 | -11.4% | 0.04% | -8.5% |
| Q4 2018 | $34,185,000 | -58.6% | 996,070 | -43.3% | 0.05% | -52.5% |
| Q3 2018 | $82,574,000 | +0.3% | 1,756,889 | -28.0% | 0.10% | -7.5% |
| Q2 2018 | $82,346,000 | +27.4% | 2,441,320 | +2.2% | 0.11% | +21.6% |
| Q1 2018 | $64,657,000 | +48.6% | 2,389,403 | -8.4% | 0.09% | +46.7% |
| Q4 2017 | $43,509,000 | -8.0% | 2,608,432 | +10.4% | 0.06% | -17.8% |
| Q3 2017 | $47,283,000 | -5.2% | 2,362,968 | -13.2% | 0.07% | -12.0% |
| Q2 2017 | $49,888,000 | +156.4% | 2,721,675 | +37.7% | 0.08% | +144.1% |
| Q1 2017 | $19,454,000 | +18.6% | 1,977,076 | +31.5% | 0.03% | +21.4% |
| Q4 2016 | $16,397,000 | +55.8% | 1,502,912 | +100.1% | 0.03% | +47.4% |
| Q3 2016 | $10,524,000 | +5109.9% | 751,177 | +2511.8% | 0.02% | – |
| Q2 2016 | $202,000 | -62.2% | 28,761 | +74.4% | 0.00% | -100.0% |
| Q4 2015 | $534,000 | -63.0% | 16,492 | -69.5% | 0.00% | -50.0% |
| Q3 2015 | $1,444,000 | +470.8% | 54,085 | +1007.2% | 0.00% | – |
| Q4 2014 | $253,000 | -60.2% | 4,885 | -79.9% | 0.00% | -100.0% |
| Q2 2014 | $635,000 | – | 24,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |